Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl added to ketamine + midazolam sedation in uncooperative pediatric dental patients
IRCT20140106016106N5Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fentanyl, ketamine and midazolam in Procedural anxiety (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Oxygen saturation, Heart rate and 6 more. Started Sep 2017; status: completed.
02
Drugs
fentanylketaminemidazolam
03
Conditions
Procedural anxiety
Beyond the preview
Go deeper on IRCT20140106016106N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140106016106N5.